OliX Pharmaceuticals, Inc.
Clinical-stage company developing RNAi therapeutics for dermal and ophthalmic diseases.
226950 | KO
Overview
Corporate Details
- ISIN(s):
- KR7226950004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 고등동 608-3 -, 성남시
- Website:
- https://olixpharma.com
- Sector:
- Manufacturing
Description
OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-03-19 00:00 |
주식매수선택권부여에관한신고
|
Korean | 16.7 KB | ||
| 2019-03-19 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 6.4 KB | ||
| 2019-03-18 00:00 |
투자판단관련주요경영사항(건성 및 습성 황반변성 치료제 OLX301A 기술이전 계약 체결)
|
Korean | 11.2 KB | ||
| 2019-03-08 00:00 |
감사보고서제출
|
Korean | 27.7 KB | ||
| 2019-02-22 00:00 |
주주총회소집공고
|
Korean | 382.6 KB | ||
| 2019-02-18 00:00 |
주주총회소집결의
|
Korean | 15.9 KB | ||
| 2019-02-14 00:00 |
기타경영사항(특허권취득)(자율공시)
|
Korean | 5.3 KB | ||
| 2019-01-31 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 13.0 KB | ||
| 2018-12-14 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.4 KB | ||
| 2018-11-14 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 6.8 KB | ||
| 2018-11-13 00:00 |
기업설명회(IR)개최
|
Korean | 7.9 KB | ||
| 2018-11-13 00:00 |
기타경영사항(특허권취득)(자율공시)(RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PEN…
|
Korean | 5.3 KB | ||
| 2018-11-13 00:00 |
분기보고서 (2018.09)
|
Korean | 689.7 KB | ||
| 2018-11-12 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.0 KB | ||
| 2018-11-12 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 110.9 KB |
Automate Your Workflow. Get a real-time feed of all OliX Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OliX Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OliX Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
